HROW
HROW
NASDAQ · Pharmaceuticals

Harrow Inc

$39.99
+0.07 (+0.18%)
As of Aug 8, 1:38 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -38.4% upside
Low Target $15.17
Average Target $24.64
High Target $37.47
Current Price $39.99
Current
$39.99
Target
$24.64
$15.17 $24.64 avg $37.47
Scenario Analysis
Bear Case
$15.17
-62.1%
Low target
Base Case
$24.64
-38.4%
Avg target
Bull Case
$37.47
+-6.3%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$54.85
-27.1% from high
52-Week Low
$28.54
+40.1% from low
Target vs 52W High
$24.64
-55.1% vs high
Next Earnings Report
Aug 10, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.18
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%